General Western Blot Reagents
Abcam Neuromedin B (porcine), Bombesin-like peptide, 1MG
MW 1132.3 Da, Purity >90%. Neuromedin B (porcine), Bombesin-like peptide. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Deltamethrin, protein phosphatase 2B inhibitor, 50MG
MW 505.2 Da, Purity >98%. Potent protein phosphatase 2B inhibitor (IC₅₀ = 0.03 nM). Induces neurotoxicity by slowing the opening and closing of Na+ channels. Active in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human NFkB p50 Transcription Factor Assay Kit.
Human NFkB p50 Transcription Factor Assay Kit.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Native Chicken Deglycosylated Avidin protein (Texas Red ), 1MG
Native Chicken Deglycosylated Avidin protein (Texas Red ), 1MG
Protein/ Peptide/ Enzyme Synonyms: Avidin, AVD
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam Native Chicken Deglycosylated Avidin protein (FITC), 1MG
Native Chicken Deglycosylated Avidin protein (FITC) is a Chicken Full Length protein, in the 1 to 152 aa range, expressed in Native, with >95% purity and suitable for ELISA, WB, Flow Cyt.
Protein/ Peptide/ Enzyme Synonyms: Avidin, AVD
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam KN-93 (water soluble), CaMK II inhibitor, 1MG
MW 599 Da, Purity >99%. Potent, specific and cell-permeable calmodulin-dependent protein kinase (CaMK) II inhibitor (IC₅₀ = 370 nM). Also a potent and direct extracellular open channel voltage-gated potassium channel blocker (IC₅₀ = 307 nM for Kv1.5); independent of CaM kinase II inhibition. Water soluble.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Cimaterol, beta adrenoceptor agonist, 50MG
MW 219.28 Da, Purity >99%. β adrenoceptor agonist (Ki = 2.32 μM). Active in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Misoprostol, Cytoprotective PGE2 analog, 1MG
MW 382.54 g/mol, Purity >98%. Cytoprotective PGE₂ analog with activity mediated by EP₂, EP₃, and EP₄ receptors (Ki values are 250, 67 and 67 nM, respectively).
The product is subject to the following: Abcam Restricted Use Statement
Abcam Tenovin-1, p53 Activator, 50MG
MW 369.48 g/mol, Purity >98%. p53 Activator. Protects p53 from MDM2 mediated degradation through SirT1 inhibition. Inhibits downstream histone acetylation, activates p21CIP/WAF1. Potent antiproliferative effects in vitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam 4-O x o-2-nonenal (4-ONE), TRPA1 activator, 5MG
MW 154.21 g/mol, Purity >98%. Lipid peroxidation product, actively modifies histidine and lysine residues on proteins and causes protein cross-linking. Shows a variety of biological activities and is a TRPA1 activator (EC₅₀ = 1.9 μM). Active in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Itraconazole, Cytochrome p450 inhibitor, 100MG
MW 705.64 g/mol, Purity >99%. Cytochrome p450 CYP3A4 inhibitor (IC₅₀ = 16-26 nM for midazolam hydroxylation). Higher affinity for fungal enzymes over mammalian cytochrome p450. Limited ability to cross the blood-brain barrier. Antifungal activity.
The product is subject to the following: Abcam Restricted Use Statement
Abcam (S)-(-)-Atenolol, beta1 adrenoceptor antagonist, 10MG
MW 266.34 g/mol, Purity >98%. Selective β₁ adrenoceptor antagonist. Orally active. Limited ability to cross the blood-brain barrier. Antihypertensive activity in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Terbutaline hemisulfate, beta2 receptor agonist, 5G
MW 274.32 g/mol, Purity >99%. Selective β₂ receptor agonist (EC₅₀ = 2.3 μM). Full agonist induces cAMP production.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Olanzapine, 5-HT, dopamine, histamine and muscarinic antagonist, 10MG
MW 312.43 g/mol, Purity >99%. 5-HT and D₂ antagonist (Ki values are 4 (5-HT₂A), 11 (5-HT₂C) and 57 (5-HT₃), 31 (D₁), 11 (D₂) and 27 nM (D₄)). Additionally, displays activity at: M₁, M₂, M₃, M₄, H₁, α₁ and α₂ receptors (Ki are 1.9 at (M₁), 18 (M₂), 25 (M₃), 13 (M₄), 19 (α₁) and 7 nM (α₂)). Atypical antipsychotic. Displays anxiolytic activity.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Dimaprit dihydrochloride, H2 agonist, 100MG
MW 234.19 Da. Selective H2 agonist. Some selectivity for H3. Does not readily cross the blood-brain barrier. Systemically active following oral administration.
The product is subject to the following: Abcam Restricted Use Statement